Google’s artificial intelligence company DeepMind is concerned that a letter written by the UK’s Information Commissioner’s Office (ICO) could have a negative impact on its business if it is published, according to sources with knowledge of the situation.
The letter — expected to be published on Friday — calls into question how DeepMind handled NHS patient data, according to sources with knowledge of the ICO’s verdict.
The ICO has been looking into DeepMind Health’s use of Royal Free patient data for its kidney monitoring app, which is known as Streams.
The regulator tasked the National Data Guardian (NDG) with investigating the partnership between DeepMind and the Royal Free.
The NDG was unhappy with the way the Royal Free used patient data to test that Streams was working safely, in advance of deploying it in care.
It concluded that “pre-deployment safety testing does not count as direct care for patients, and that implied consent is therefore not a sufficient basis,” according to a document seen by Business Insider.
The ICO is planning to make its official verdict on the DeepMind partnership with the NHS public in the coming weeks.
DeepMind did not immediately respond to Business Insider’s request for comment.